| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.45 | 0.01 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |